Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

ANTINUCLEAR ANTIBODY (ANA) - ANVISA Registration 80406120013

Access comprehensive regulatory information for ANTINUCLEAR ANTIBODY (ANA) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80406120013 and manufactured by BIO GENETIX SRL. The registration is held by BYOBRASIL COMÉRCIO DE EQUIPAMENTOS MÉDICO HOSPITALARES E SEUS INSUMOS LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including INOVA DIAGNOSTICS, INC., ORGENTEC DIAGNOSTIKA GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
80406120013
Registration Details
ANVISA Registration Number: 80406120013
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Device Details

ENEA AUTOIMMUNE IgG – NUC
Risk Class II

Registration Details

80406120013

25351314392201097

08317750000101

Company Information

BIO GENETIX SRL
Italy
PT: ITÁLIA

Dates and Status

Nov 22, 2010

VIGENTE

09/18/2025 19:00:01